Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Korean company targets Middle-East heart disease problem:

This article was originally published in Clinica

Executive Summary

Heart disease and diabetes have been identified by regional authorities in the Middle East as two of the most significant causes of death. Statistics from the UAE ministry of health has said that heart disease accounts for a quarter of the nation's deaths each year. This has prompted German medical electronics company Sein Electronics to target the area for its heart and body fat monitoring system. It is due to launch the system at the Arab Health 2002 exhibition in Dubai in January. As a means of combating the region's growing prevalence of heart disease, there is an increasing trend towards healthcare monitoring at home in the Middle East, says Diete Bunte, managing director of Sein Electronics.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074338

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel